Prelude and MSD partner to trial PRT3789 and Keytruda combination
MSD will supply KEYTRUDA for the combination trial, with Prelude acting as the sponsor.
10 July 2024
10 July 2024
MSD will supply KEYTRUDA for the combination trial, with Prelude acting as the sponsor.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.